Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience

PURPOSE: To present our real-life experience with dabrafenib and trametinib (D-T) treatment in patients with BRAF V600E-mutated ATC in Argentina. PATIENTS Y METHODS: We included five patients from four different hospitals. The median age was 70 years, and 60% were male. The performance status at dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bueno, Fernanda, Smulever, Anabella, Califano, Inés, Guerra, Jorgelina, Del Grecco, Andrés, Carrera, Juan Manuel, Giglio, Raúl, Rizzo, Manglio, Lingua, Alejo, Voogd, Ana, Negueruela, María del Carmen, Abelleira, Erika, Pitoia, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838471/
https://www.ncbi.nlm.nih.gov/pubmed/36617605
http://dx.doi.org/10.1007/s12020-022-03295-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838471/
https://www.ncbi.nlm.nih.gov/pubmed/36617605
http://dx.doi.org/10.1007/s12020-022-03295-2

Ejemplares similares